|
E2F6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.69304628281498E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.49159948018507E-10 |
| Normal-vs-Stage2 |
1.779280E-04 |
| Normal-vs-Stage3 |
1.589600E-04 |
| Normal-vs-Stage4 |
6.735400E-03 |
| Stage1-vs-Stage2 |
5.506400E-01 |
| Stage1-vs-Stage3 |
1.613350E-01 |
| Stage1-vs-Stage4 |
8.360200E-02 |
| Stage2-vs-Stage3 |
4.376400E-01 |
| Stage2-vs-Stage4 |
1.422780E-01 |
| Stage3-vs-Stage4 |
2.561000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77100564716193E-12 |
| Normal-vs-AfricanAmerican |
2.70109999922497E-08 |
| Normal-vs-Asian |
7.864000E-02 |
| Caucasian-vs-AfricanAmerican |
7.356200E-01 |
| Caucasian-vs-Asian |
2.381600E-01 |
| AfricanAmerican-vs-Asian |
3.914200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53900225896564E-11 |
| Normal-vs-Female |
6.65949517753006E-11 |
| Male-vs-Female |
2.526100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.05539999997839E-06 |
| Normal-vs-Extreme_Weight |
1.05120000482017E-08 |
| Normal-vs-Obese |
1.18590000042218E-07 |
| Normal-vs-Extreme_Obese |
1.192480E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.450400E-01 |
| Normal_Weight-vs-Obese |
8.201800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.481400E-01 |
| Extreme_Weight-vs-Obese |
3.755000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.748200E-01 |
| Obese-vs-Extreme_Obese |
5.806400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35389999999613E-05 |
| Normal-vs-Age(41-60Yrs) |
1.0369483049999E-13 |
| Normal-vs-Age(61-80Yrs) |
1.59090000062534E-08 |
| Normal-vs-Age(81-100Yrs) |
2.801400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.512070E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.159120E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.662000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.184400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.340400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.631600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64879221387082E-12 |
| Normal-VS-Type2 PRCC |
1.434960E-04 |
| Normal-VS-KIRP CIMP |
1.256580E-03 |
| Normal-VS-Unclassified PRCC |
5.232400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.216300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.217400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.736800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.646400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.885000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.702900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55702999999896E-05 |
| Normal-vs-N1 |
4.34670000000192E-05 |
| Normal-vs-N2 |
3.406200E-02 |
| N0-vs-N1 |
2.280200E-03 |
| N0-vs-N2 |
2.411800E-02 |
| N1-vs-N2 |
6.355200E-01 |
|
|
